Multiple Sclerosis: Myelin May Be Detrimental to Nerve Fibers
https://reachmd.com/news/multiple-sclerosis-myelin-may-be-detrimental-to-nerve-fibers/2451704/
Multiple sclerosis (MS) is a serious neurological disease that usually causes permanent disability. Approximately 2.9 million people are affected worldwide, 240,000 in Germany alone. The exact cause of the disease is not yet clear, but a central feature is a loss of the insulating protective layer …
Safety & Immunogenicity of COVID-19 mRNA Vaccine SYS6006 Evaluated in Phase 1 Trial
https://reachmd.com/news/safety-immunogenicity-of-covid-19-mrna-vaccine-sys6006-evaluated-in-phase-1-trial/2451680/
by Higher Education Press RBD-binding antibodies to omicron BA.2 and BA.4…
Staging Pancreatic Cancer Early with Minimally Invasive Surgery Shows Positive Results in Patient Prognosis, Finds Study
https://reachmd.com/news/staging-pancreatic-cancer-early-with-minimally-invasive-surgery-shows-positive-results-in-patient-prognosis-finds-study/2451672/
Trend in laparoscopy performed as a separate staged procedure vs immediately before resection. Staged procedures increased significantly over time (p < 0.001). Credit: Journal of the American College of Surgeons (2023). DOI: 1…
Preoperative HIIT & Cardiorespiratory Fitness & Postoperative Outcomes
https://reachmd.com/news/preoperative-hiit-cardiorespiratory-fitness-postoperative-outcomes/2451682/
Key PointsQuestion What is the evidence for the efficacy of preoperative high-intensity interval training (HIIT) in improving cardiorespiratory fitness and surgical outcomes?Findings This systematic review and meta-analysis of 12 studies including 832 patients assessed…
Design of a Novel Chimeric Peptide via Dual Blockade of CD47/SIRPα & PD-1/PD-L1 for Cancer Immunotherapy
https://reachmd.com/news/design-of-a-novel-chimeric-peptide-via-dual-blockade-of-cd47sirp-pd-1pd-l1-for-cancer-immunotherapy/2451705/
SCIENCE CHINA Life Sciences published a research article online by Professor Yanfeng Gao’s team from the School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University. They designed and synthesized Pal-DMPOP, a chimeric peptide that can simultaneously block CD47/SIRPα and PD-1/PD-L1. This b…
Study Finds Link Between Blood Type & COVID-19 Susceptibility
https://reachmd.com/news/study-finds-link-between-blood-type-covid-19-susceptibility/2451688/
Ask the average American what their blood type is, and you will likely receive a blank look. For most people, blood type only becomes an issue if they need a blood transfusion. Beginning in the earliest days of the COVID-19 pandemic, however, results from previous work published in …
The Truth About Emulsifiers: Are They Destroying Our Gut Health?
https://reachmd.com/news/the-truth-about-emulsifiers-are-they-destroying-our-gut-health/2451674/
As if excess salt, fat and several types of sugar weren’t bad enough, the ingredient lists of much ultra-processed food often end with a befuddling number of additives. Either written as E numbers or given their full chemical names, this information is unsettlingly opaque to non-experts, prompting …
Uterine Cancer Deaths Could Soon Outnumber Deaths from Ovarian Cancer, Oncologist Says: ‘We Need To Do Better’
https://reachmd.com/news/uterine-cancer-deaths-could-soon-outnumber-deaths-from-ovarian-cancer-oncologist-says-we-need-to-do-better/2451665/
Cancer patient Jeff Bolle and his wife Connie joined 'America's Newsroom' to discuss how they have been battling the shortages and their broader concerns surrounding the lack of treatment. The most common type of gynecologic cancer in the U.S. has been on the rise in recent years — and there’s n…
New Research Links Isolation in Old Age to Negative Health Outcomes
https://reachmd.com/news/new-research-links-isolation-in-old-age-to-negative-health-outcomes/2451663/
By Brennen Jensen / Published Summer 2023 For many, keepi…
You’ll Soon Be Able to Get a Blood Test for Alzheimer’s. Will You Want One?
https://reachmd.com/news/youll-soon-be-able-to-get-a-blood-test-for-alzheimers-will-you-want-one/2451699/
When Daniel Gibbs, M.D., enrolled in an Alzheimer’s study at UC San Francisco almost a decade ago, researchers needed access to a secure government facility just to confirm that he had the disease. They summoned Gibbs to the Lawrence Berkeley National Laboratory, hooked him up to an IV, and wheeled…